Found: 36
Select item for more details and to access through your institution.
Subclinical Hypothyroidism and Metabolic Syndrome: A Common Association by Chance or a Cardiovascular Risk Driver?
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Synergistic Interactions Among Metabolic Syndrome Components and Homeostasis Model Assessment of Insulin Resistance in a Middle-Aged General Population over Time.
- Published in:
- Metabolic Syndrome & Related Disorders, 2015, v. 13, n. 4, p. 171, doi. 10.1089/met.2014.0163
- By:
- Publication type:
- Article
Response to Chia Siang Kow and colleagues.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus.
- Published in:
- Acta Diabetologica, 2019, v. 56, n. 6, p. 605, doi. 10.1007/s00592-018-1271-3
- By:
- Publication type:
- Article
Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0910-5
- By:
- Publication type:
- Article
Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Stem Cells Translational Medicine, 2020, v. 9, n. 9, p. 965, doi. 10.1002/sctm.20-0020
- By:
- Publication type:
- Article
Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2020, v. 13, p. 161, doi. 10.2147/DMSO.S233538
- By:
- Publication type:
- Article
Effects of Hypoglycemia on Circulating Stem and Progenitor Cells in Diabetic Patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Circulating Stem Cells Associate With Adiposity and Future Metabolic Deterioration in Healthy Subjects.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells.
- Published in:
- Diabetologia, 2023, v. 66, n. 12, p. 2346, doi. 10.1007/s00125-023-06002-6
- By:
- Publication type:
- Article
Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial.
- Published in:
- Diabetologia, 2021, v. 64, n. 10, p. 2334, doi. 10.1007/s00125-021-05532-1
- By:
- Publication type:
- Article
Diabetes mellitus impairs circulating proangiogenic granulocytes.
- Published in:
- Diabetologia, 2020, v. 63, n. 9, p. 1872, doi. 10.1007/s00125-020-05142-3
- By:
- Publication type:
- Article
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2390, doi. 10.1111/dom.15554
- By:
- Publication type:
- Article
Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: A pooled analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 3, p. 522, doi. 10.1111/dom.14609
- By:
- Publication type:
- Article
Exposure to dipeptidyl‐peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1925, doi. 10.1111/dom.14142
- By:
- Publication type:
- Article
Exposure to dipeptidyl‐peptidase‐4 inhibitors and COVID‐19 among people with type 2 diabetes: A case‐control study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1946, doi. 10.1111/dom.14097
- By:
- Publication type:
- Article
Dipeptidyl peptidase‐4 inhibitors moderate the risk of genitourinary tract infections associated with sodium‐glucose co‐transporter‐2 inhibitors.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 740, doi. 10.1111/dom.13130
- By:
- Publication type:
- Article
Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: An updated review of the literature.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 1, p. 25, doi. 10.1111/dom.13012
- By:
- Publication type:
- Article
Circulating stem cells and cardiovascular outcomes: from basic science to the clinic.
- Published in:
- European Heart Journal, 2020, v. 41, n. 44, p. 4271, doi. 10.1093/eurheartj/ehz923
- By:
- Publication type:
- Article
p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complications.
- Published in:
- Cardiovascular Diabetology, 2018, v. 17, p. 1, doi. 10.1186/s12933-018-0660-9
- By:
- Publication type:
- Article
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial.
- Published in:
- Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-017-0529-3
- By:
- Publication type:
- Article
DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes.
- Published in:
- Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-017-0507-9
- By:
- Publication type:
- Article
Circulating haematopoietic stem cells and long‐term outcomes of COVID‐19.
- Published in:
- European Journal of Clinical Investigation, 2024, v. 54, n. 4, p. 1, doi. 10.1111/eci.14150
- By:
- Publication type:
- Article
SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01243-4
- By:
- Publication type:
- Article
Glycaemic Control Achieves Sustained Increases of Circulating Endothelial Progenitor Cells in Patients Hospitalized for Decompensated Diabetes: An Observational Study.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 7, p. 1327, doi. 10.1007/s13300-022-01273-5
- By:
- Publication type:
- Article
Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 6, p. 1369, doi. 10.1007/s13300-020-00829-7
- By:
- Publication type:
- Article
Angiogenic Abnormalities in Diabetes Mellitus: Mechanistic and Clinical Aspects.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effects of SGLT2 Inhibitors on Circulating Stem and Progenitor Cells in Patients With Type 2 Diabetes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo.
- Published in:
- Acta Diabetologica, 2018, v. 55, n. 6, p. 593, doi. 10.1007/s00592-018-1129-8
- By:
- Publication type:
- Article
The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast Italy.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+CD133+ Stem Cells in Patients With Type 2 Diabetes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effects of Age, Diabetes, and Vascular Disease on Growth Differentiation Factor 11: First-in-Human Study.
- Published in:
- Diabetes Care, 2015, v. 38, n. 8, p. e118, doi. 10.2337/dc15-0868
- By:
- Publication type:
- Article
Hematopoietic progenitor cell liabilities and alarmins S100A8/A9‐related inflammaging associate with frailty and predict poor cardiovascular outcomes in older adults.
- Published in:
- Aging Cell, 2022, v. 21, n. 3, p. 1, doi. 10.1111/acel.13545
- By:
- Publication type:
- Article
Euglycemic Ketoacidosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19.
- Published in:
- Diabetes, 2022, v. 71, n. 4, p. 788, doi. 10.2337/db21-0965
- By:
- Publication type:
- Article